Curis Lifesciences Limited IPO
NSE SME₹ 256000 /2000 Shares
*Min Investment
07 Nov, 2025
Open Date11 Nov, 2025
Close Date12 Nov, 2025
Allotment Date14 Nov, 2025
Listing DateCuris Lifesciences IPO Issue Details
- Issue Price ₹120-128 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 21,50,000 shares(aggregating up to ₹27.52 crore)
- Fresh Share 21,50,000 shares(aggregating up to ₹27.52 crore)
- Listing at NSE SME
- Lead Manager Finaax Capital Advisors Private Limited
- Registrar MUFG Intime India Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2000 | ₹2,56,000 |
| Individual(max) | 2 | 2000 | ₹2,56,000 |
| SHNI(min) | 3 | 3000 | ₹3,84,000 |
| SHNI(max) | 7 | 7000 | ₹8,96,000 |
| BHNI(min) | 8 | 8000 | ₹10,24,000 |
Curis Lifesciences IPO Reservation
Curis Lifesciences IPO offers total 0 shares. Out of which NA (NA%) allocated to QIB, 0 (NA%) allocated to NII,0 (NA%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (NA%) | |
| Market Maker Shares Offered | NA (NA%) | |
| QIB Shares Offered | NA (NA%) | |
| NII (HNI) Shares Offered | 0 (NA%) | |
| Individual Shares Offered | 0 (NA%) | |
| Total Shares Offered | 0 (100%) |
Curis Lifesciences IPO Details
Curis Lifesciences Limited IPO is an SME IPO, priced at ₹120-128 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 21,50,000 equity shares, aggregating up to ₹27.52 crores..
The IPO bidding window is open from Nov 7, 2025 to Nov 11, 2025. The allotment is expected to be finalized on Nov 12, 2025, and the tentative listing date is Nov 14, 2025.
The minimum lot size for Individual investors is 2000 shares, with a minimum investment of ₹2,56,000.
Finaax Capital Advisors Private Limited is acting as the lead manager to the issue. The registrar of the IPO is MUFG Intime India Pvt.Ltd., and
Curis Lifesciences Valuations
Curis Lifesciences Company Financials
| 31-Dec-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|---|
| Assets | 50.12 | 33.82 | 29.67 | 27.40 |
| Revenue | 36.91 | 35.89 | 36.39 | 23.76 |
| Profit After Tax | 5.30 | 5.03 | 1.85 | 0.49 |
| Net Worth | 15.53 | 5.97 | 0.95 | 0.90 |
| Reserves & Surplus | 9.59 | 5.47 | 0.45 | -1.40 |
| Total Borrowing | 16.16 | 17.09 | 16.19 | 17.62 |
About Curis Lifesciences Company
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products.
The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include:
General pharmaceutical tablets and capsules
Oral liquids
External preparations
Sterile ophthalmic ointments
The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Curis Lifesciences - Promoter(s)
Mr. Dharmesh Dashrathbhai Patel
Mr. Siddhant Jayantibhai Pawasia
Mr. Piyush Gordhanbhai Antala
Mr. Jaimik Mansukhbhai Patel
Pre Issue Share Holding : 92.68%
Post Issue Share Holding : 68.03%
Curis Lifesciences IPO - Issue Objectives
Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities
Capital Expenditure towards Construction of a Storage Facility
Pre-payment/Repayment of outstanding Secured Loans
Product Registrations in other countries
Funding our Working Capital Requirements
General Corporate Purposes
Contact Details
Curis Lifesciences
PF-23, GIDC Sanand - II, Industrial Estate, Sanand, Ahmedabad, Gujarat, 382110
+91 99045 22543
Registrar Contact Details
MUFG Intime India Private Limited (Link Intime)
+91-22-4918 6270
Curis Lifesciences IPO - FAQs
Ans. Curis Lifesciences Limited IPO is a SME IPO. The issue is priced at ₹120-128 per equity share. The minimum order quantity is 1000 Shares. The IPO opens on Nov 7, 2025, and closes on Nov 11, 2025. MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Curis Lifesciences Limited IPO opens on Nov 7, 2025 and closes on Nov 11, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Curis Lifesciences Limited IPO is 21,50,000 shares(aggregating up to ₹27.52 Cr).
Ans. The Curis Lifesciences Limited IPO price band is set between ₹120-128 per equity share.
Ans. To apply for Curis Lifesciences Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Curis Lifesciences Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Curis Lifesciences Limited IPO is Nov 12, 2025.
Ans. The Curis Lifesciences Limited IPO will be listed on Nov 14, 2025.
Ans. Follow the steps to check the Curis Lifesciences Limited IPO allotment status online.
